Scleroderma Research Foundation: Molecular Pathogenesis and New Interventions in Scleroderma

The Scleroderma Research Foundation is accepting applications for Molecular Pathogenesis and New Interventions in Scleroderma. Award is up to $600,000 over three years. Applications are encouraged from applicants who have not previously worked on scleroderma, as well as those with substantial ongoing scleroderma-focused efforts. Application deadline is Dec. 4, 2015.

The UNC Office of Corporate and Foundation Relations has identified the following private funding opportunity:

Scleroderma Research Foundation: Molecular Pathogenesis and New Interventions in Scleroderma
http://www.srfcure.org

The foundation is supporting projects that foster the development of research to advance the understanding of the pathogenesis of scleroderma and to promote the design, development and pilot testing of hypothesis-driven innovative therapeutic approaches. Applications are encouraged from scientists who have not previously worked on scleroderma, as well as those with substantial ongoing scleroderma-focused efforts. Funding mechanism is by the Investigator-Initiated Research Grant (SRF01), the Exploratory/Developmental Research Grant (SRF02) and the New Faculty Grant (SRF03).

Potential areas of interest include:

  • Studies on the initiation and propagation of the fibrotic process in scleroderma, in particular the interaction of the disease process with the immune system.
  • The study of molecular and cellular events that contribute to vascular reactivity and vasculopathy in scleroderma.
  • Pharmacologic and alternative approaches leading to reduction of GI symptoms and GI tissue injury in scleroderma patients.
  • New approaches to reduce progressive scleroderma lung disease.
  • New animal models to elucidate scleroderma pathogenesis and test new therapies.
  • Analysis of gene expression patterns that may contribute to disease onset or progression of scleroderma.
  • Studies on biomarkers and new diagnostic methodologies to monitor progression of scleroderma.
  • Translational studies with currently available drugs to treat scleroderma based on new therapeutic or mechanistic hypotheses.

Application Deadline: Dec. 4, 2015. Application Guidelines for the award. 

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. Email cfr@unc.edu or phone 919-962-3423. 

Filed under: